作为抗癌剂的库库比他B的最新进展
Dongge Yin1, Hongyue Chen1, Shuting Lin1
1School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
International journal of molecular sciences
|August 28, 2025
概括
库库比他素B (CuB) 是一种植物性化合物,通过诱导细胞死亡和抑制瘤生长,具有广泛的抗癌活性. 研究探索通过改进和传递系统来提高其潜力,以改善癌症治疗.
科学领域:
- 自然产品化学
- 药理学
- 癌症学
背景情况:
- 库库比他素B (CuB) 是来自Cucurbitaceae植物的四环三胺,在肝脏疾病的辅助治疗中具有历史性的用途.
- CuB对包括肝脏,胃和结直肠在内的多种癌细胞具有抑制作用.
- 自20世纪70年代至80年代以来,
研究的目的:
- 系统地审查Cucurbitacin B的物理化学特性,抗癌机制和应用策略.
- 在科学研究和临床转化中确定Cucurbitacin B的未来研究方向.
- 提供CUB在癌症治疗中的潜力的全面概述.
主要方法:
- 文献综述关于库库比他B的现有研究.
- 对CuB多种抗癌机制的分析,包括细胞亡,细胞循环停止,自和抗血管生成.
- 检查涉及CuB影响的信号通路,如JAK/STAT和PI3K/Akt/mTOR.
主要成果:
- 通过各种机制表现出广泛的抗癌活性,如诱导细胞亡,细胞循环停止以及抑制迁移和血管生成.
- 由CuB调节的关键路径包括JAK/STAT,PI3K/Akt/mTOR和FOXM1-KIF20A.
- 像结构修改,组合疗法和纳米材料输送等策略提高了CuB的有效性和生物可用性.
结论:
- 库库比他素B具有显著的抗癌潜力,具有多种作用机制.
- 需要进一步研究以阐明细胞特异性敏感性和免疫系统相互作用.
- 优化应用策略对于在临床环境中推进CuB至关重要.
更多相关视频
06:39Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
Published on: October 27, 2023
1.1K
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
14.1K
相关概念视频
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
